ArticleFrontiers in oncology2020

What Multiple Myeloma With t(11;14) Should Be Classified Into in Novel Agent Era: Standard or Intermediate Risk?

Wen Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.